New York City-based researchers reported that a leadless cardiac pacemaker (Nanostim/St. Jude Medical) implanted non-surgically via a catheter through the femoral vein had a better safety record than conventional devices. But it has other limitations.
The first real-world study of its kind revealed that rivaroxaban, marketed as Xarelto, can reduce the risk of stroke and major bleeding in patients with atrial fibrillation (AF) – a group that is five times more likely to suffer a stroke compared to the general population.
Research has established that various parts of the trigeminal system are responsible for peripheral symptoms of migraine. Treatment with corticosteroids reduces the symptoms of migraine, but the treatment is associated with long-term side effects.
With the exception of perhaps stroke neurologists, who see the devastating effects of stroke every day, many other physicians let fear guide their anticoagulation treatment decisions, according to the experts.
In atrial fibrillation, aspirin could double a patient’s risk for bleeding. And yet, it is still used all the time. Hear the experts discuss the importance of using a “real” anticoagulant for patients who need to be anticoagulated.